First experimental study in humans finds low-dose exposure to bisphenol A alters insulin response to oral and IV glucose, possibly increases diabetes 2 risk
September 12, 2018
Opinion: FDA ‘rushing to judgement’ on BPA
Article in Environmental Health News discusses main goal of CLARITY-BPA program and U.S. FDA’s premature conclusions on BPA hazards
September 11, 2018
Webinar on CLARITY-BPA core study
U.S. Food and Drug Administration hosts webinar on guideline studies conducted within CLARITY-BPA program, September 13, 2018; registration now open
September 11, 2018
Webinar on CLARITY-BPA academic studies
Carnegie Mellon University holds webinar on independent academic studies on bisphenol A within CLARITY-BPA program, September 12, 2018; registration now open
September 7, 2018
Gaps in risk assessment of nanopigments
EU Observatory for Nanomaterias reviews knowledge on hazard and risk assessment of nano-sized pigments, finds information gaps, calls for further research, increased reporting transparency
September 7, 2018
REACH data insufficient to classify carcinogens and mutagens
RIVM scientists find data required by REACH to be insufficient for classifying category 1B carcinogens and mutagens according to criteria set by Classification, Labeling and Packaging legislation
September 7, 2018
Mechanistic data in hazard assessment
Academic and industry scientists debate whether use of mechanistic data in regulatory hazard assessment of chemicals should be decisive or supportive only, discuss study selection process for systematic reviews
September 6, 2018
2019 ILSI NA workshop on FCMs
ILSI North America hosts international conference on scientific advances and challenges in safety evaluation of food packaging materials, April 2-3, 2019; deadline for submitting abstracts is September 14, 2018; registration now open
August 29, 2018
Can regulation keep up with science?
Article by Undark discusses scientific advances in toxicology, urges U.S. EPA to incorporate new knowledge on toxic chemicals
August 27, 2018
OECD guideline on development toxicity updated
OECD adds endpoints to prenatal development toxicity testing guideline to better detect effects of endocrine disruptors
